The assessment of “Global Biosimilar Market” report which is estimated to achieve the market return at 58.40 Billion USD with CAGR of 52.77% during the upcoming forecast period and Biosimilar market evaluation for the year 2018 XX USD and predicated to appraise tremendously to XX USD by 2023.

The objective of Global Biosimilar Market report is to enlighten the users with up-to-date market stats, market trends, Biosimilar market outlook during the forecast period from 2018-2023. The Biosimilar market size, market overview, business tactics of the leading players and the analysis of market-based on the past, present and future dominating trends will bring the market growth, market strategies, and Biosimilar development status during the forecast period. The precise Biosimilar market study in chunks based on key market segments, dominant geographic regions, exclusive market players and Biosimilar business opportunities will help in making vital business conclusions.

Influence of the global Biosimilar market report:

* Biosimilar market analyzes extensive interpretation of all opportunities and objections.

* Competitive developments, strategic alliances, mergers & acquisitions and Biosimilar research & developments.

* Biosimilar market latest tech innovations and key events.

* Detailed analysis of business strategies of the Biosimilar market top key players.

* Growth map decisive analysis of Biosimilar market in forthcoming years.

* Deeper insights of Biosimilar industry-specific drivers, restraints and key micro markets.

* Beneficial instincts inside crucial technological and market trends impacting the Biosimilar market.

The compelling points of the Biosimilar report are the complete study of key leading market performers, their competitive scenario, segment-wise analysis of Biosimilar market, a study of market competitors, their consumer base, demand and supply chain scenario and competitive factors. The Biosimilar product application, manufacturing cost, labour cost, raw materials, key developments and Biosimilar innovative strategies are listed in this report.

Global Biosimilar Market leading players & major geographical regions include:

The global Biosimilar market is segmented on the basis leading players in Biosimilar market includes 

Amgen Inc
Astra Zeneca Plc
Biocon Ltd
Pfizer Inc
Novartis International AG
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd

Biosimilar industry in North America includes US, Canada, Mexico

Biosimilar industry in Europe includes Germany, UK, France

Biosimilar industry in Middle East & Africa includes Saudi Arabia, South Africa, Egypt

Biosimilar industry in Asia-Pacific includes China, Japan, India, Singapore

According to the applications, Biosimilar market divided into:

Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases

Based on the types, the Biosimilar market is categorized into:

Recombinant Non-Glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides

Target Audience:

* Major key vendors in the Biosimilar market

* Global Biosimilar Industry suppliers and distributors

* Research Organizations and Consulting Firms

* Biosimilar Research and Development (R&D) Companies and Academic Centers

In short, the global Biosimilar market offers the fundamental market synopsis, along with the Biosimilar sales revenue, market profits, market share of Biosimilar players, SWOT analysis based on manufacturing regions, analysis of modern market trends and conclusions. The Biosimilar report will serve as a complete guide for emerging and existing market players and aspirants for gaining a competitive business advantage.
https://market.biz/report/global-biosimilar-market-smr/119023/#inquiry
1.MARKET OVERVIEW

1.1.Definitions

1.2.Market Segmentation

1.3.Research Methodology

1.4.Assumptions

2.EXECUTIVE SUMMARY

3.MARKET DYNAMICS

3.1.Drivers

3.2.Restraints
1.MARKET OVERVIEW

1.1.Definitions

1.2.Market Segmentation

1.3.Research Methodology

1.4.Assumptions

2.EXECUTIVE SUMMARY

3.MARKET DYNAMICS

3.1.Drivers

3.2.Restraints

3.3.Opportunities

3.4.Trends

4.INDUSTRY ANALYSIS

4.1.Industry Overview

4.2.Regulatory Analysis

4.2.1.European Medicines Agency (EMA)

4.2.2.U.S. FDA

4.2.3.India

4.2.4.Latin America

4.2.5.Other Asia-Pacific Countries

4.3.Time to Entry Analysis

4.4.Pipeline Analysis

4.5.Pricing Analysis

4.6.Stakeholders Analysis

5.BIOSIMILARS MARKET, BY PRODUCT TYPES

5.1.Market Overview

5.2.Market Share Segmentation

5.3.Revenue Segmentation

5.4.Product Types

5.4.1.Recombinant Glycosylated Proteins

5.4.2.Recombinant Non-Glycosylated Proteins

5.4.3.Recombinant Peptides

6.BIOSIMILARS MARKET, BY APPLICATIONS

6.1.Market Overview

6.2.Market Share Segmentation

6.3.Applications

6.3.1.Oncology

6.3.2.Blood Disorders

6.3.3.Infectious Diseases

6.3.4.Autoimmune Diseases

6.3.5.Other Diseases

7.BIOSIMILARS MARKET, BY REGIONS

7.1.Geographic Overview

7.2.Market Share Segmentation

7.3.Revenue Segmentation

7.4.Volume Segmentation

7.5.North America

7.5.1.By Regions

7.5.1.1.U.S.

7.5.1.2.Canada

7.5.2.By Product Type

7.5.3.By Applications

7.6.Europe

7.6.1.By Regions

7.6.1.1.Germany

7.6.1.2.U.K

7.6.1.3.France

7.6.1.4.Italy

7.6.1.5.Rest of Europe

7.6.2.By Product Type

7.6.3.By Applications

7.7.Asia-Pacific

7.7.1.By Regions

7.7.1.1.China

7.7.1.2.India

7.7.1.3.Russia

7.7.1.4.Australia

7.7.1.5.Japan

7.7.1.6.South Korea

7.7.1.7.Rest of Asia-Pacific

7.7.2.By Product Type

7.7.3.By Applications

7.8.Middle East& Africa

7.8.1.By Regions

7.8.1.1.Egypt

7.8.1.2.South Africa

7.8.1.3.Nigeria

7.8.1.4.Rest of Middle East& Africa

7.8.2.By Product Type

7.8.3.By Applications

7.9.Latin America

7.9.1.By Regions

7.9.1.1.Brazil

7.9.1.2.Argentina

7.9.1.3.Columbia

7.9.1.4.Mexico

7.9.1.5.Rest of Latin America

7.9.2.By Product Type

7.9.3.By Applications

8.COMPETITIVE LANDSCAPE

8.1.Market Share Analysis

9.KEY MARKET PLAYERS

9.1.Amgen Inc.

9.1.1.Overview

9.1.2.Key Strategies

9.1.3.Recent Developments

9.2.AstraZeneca, plc

9.2.1.Overview

9.2.2.Key Strategies

9.2.3.Recent Developments

9.3.Pfizer Inc.

9.3.1.Overview

9.3.2.Key Strategies

9.3.3.Recent Developments

9.4.Biocon Ltd.

9.4.1.Overview

9.4.2.Key Strategies

9.4.3.Recent Developments

9.5.Novartis International AG

9.5.1.Overview

9.5.2.Key Strategies

9.5.3.Recent Developments

9.6.STADA Arzneimittel AG

9.6.1.Overview

9.6.2.Key Strategies

9.6.3.Recent Developments

9.7.Teva Pharmaceuticals Industries Ltd.

9.7.1.Overview

9.7.2.Key Strategies

9.7.3.Recent Developments

10.LAST WORD: SCALAR 360 DEGREE MARKET PERSPECTIVE

11.APPENDIX


LIST OF TABLES

Table 1.  Research Methodology

Table 2.  Assumptions

Table 3.  Global Biosimilars Market Size (US$ Billion), (2016-2022)

Table 4.  Global Biosimilars Volume (Million Units), (2014-2022)

Table 5.  EMA Approved Biosimilars

Table 6.  U.S. FDA Approved Biosimilars

Table 7.  Approved Biosimilars in India

Table 8.  Biosimilars Approved, Marketed in Latin America

Table 9.  Biosimilars Approved, Marketed in Australia

Table 10. Time to Entry Analysis (Generics vs. Biologics vs. Biosimilars)

Table 11. Time to Market Entry for Biosimilars from EMAs approval

Table 12. Top Selling Biologic Products to lose patent in the coming years (Sales in US$ Billion)

Table 13. Companies with largest number of Biosimilars in Pipeline (2015)

Table 14. Top Biosimilars in Phase 3 Stage of the Development

Table 15. Development & Investment Costs (Generics vs. Biologics vs. Biosimilars)

Table 16. Pricing of Top Biosimilars Products with Average Market Price(2015)

Table 17. Impact of the Growth of Biosimilars Market on Stakeholders

Table 18. Global Biosimilars Market Size (US$ Billion), By Product Types (2014 2022)

Table 19. Global Recombinant Glycosylated ProteinsBiosimilars Market Size (US$ Billion), By Regions (2014-2022)

Table 20. Global Recombinant Non-Glycosylated ProteinsBiosimilars Market Size (US$ Billion),By Regions (2014-2022)

Table 21. Global Recombinant Peptides Biosimilars Market Size (US$ Billion), By Regions (2014-2022)

Table 22. Global Biosimilars Market Size (US$ Billion), By Applications (2014-2022)

Table 23. Global Biosimilars Market for Oncology; Market Size (US$ Billion) (2014-2022)

Table 24. Global Biosimilars Market for Blood Disorders; Market Size (US$ Billion) (2014-2022)

Table 25. Global Biosimilars Market for Infectious Diseases; Market Size (US$ Billion) (2014-2022)

Table 26. Global Biosimilars Market for Autoimmune Diseases; Market Size (US$ Billion) (2014-2022)

Table 27. Global Biosimilars Market for Other Diseases; Market Size (US$ Billion) (2014-2022)

Table 28. Biosimilars Market Prospects, by Geography (2016-2022)

Table 29. Global Biosimilars Market Size (US$ Billion), By Regions (2014-2022)

Table 30. Global Biosimilars Market; Market Size, By Major Countries (2014-2022)

Table 31. Global Biosimilars Volume (Million Units), (2014-2022)

Table 32. Biosimilars Market in North America; Market Size (US$ Billion) (2014-2022)

Table 33. Biosimilars Market in U.S; Market Size (US$ Billion), (2014-2022)

Table 34. Biosimilars Market in Canada; Market Size (US$ Billion), (2014-2022)

Table 35. Biosimilars Market in North America; Market Size (US$ Billion), By Product Type (2014-2022)

Table 36. Biosimilars Market in North America; Market Size (US$ Billion), By Applications (2014-2022)

Table 37. Biosimilars Market in Europe; Market Size (US$ Billion)

Table 38. Biosimilars Market in Germany; Market Size (US$ Billion), (2014-2022)

Table 39. Biosimilars Market in U.K; Market Size (US$ Billion), (2014-2022)

Table 40. Biosimilars Market in France; Market Size (US$ Billion), (2014-2022)

Table 41. Biosimilars Market in Italy; Market Size (US$ Billion), (2014-2022)

Table 42. Biosimilars Market in Rest of Europe; Market Size (US$ Billion), (2014-2022)

Table 43. Biosimilars Market in Europe; Market Size (US$ Billion), By Product Type (2014-2022)

Table 44. Biosimilars Market in Europe; Market Size (US$ Billion), By Applications (2014-2022)

Table 45. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion)

Table 46. Biosimilars Market in China; Market Size (US$ Billion), (2014-2022)

Table 47. Biosimilars Market in India; Market Size (US$ Billion), (2014-2022)

Table 48. Biosimilars Market in Russia; Market Size (US$ Billion), (2014-2022)

Table 49. Biosimilars Market in Australia; Market Size (US$ Billion), (2014-2022)

Table 50. Biosimilars Market in Japan; Market Size (US$ Billion), (2014-2022)

Table 51. Biosimilars Market in South Korea; Market Size (US$ Billion), (2014-2022)

Table 52. Biosimilars Market in Rest of Asia-Pacific; Market Size (US$ Billion), (2014-2022)

Table 53. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion), By Product Type (2014-2022)

Table 54. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion), By Applications (2014-2022)

Table 55. Biosimilars Market in Middle East& Africa; Market Size (US$ Billion)

Table 56. Biosimilars Market in Egypt; Market Size (US$ Billion), (2014-2022)

Table 57. Biosimilars Market in South Africa; Market Size (US$ Billion), (2014-2022)

Table 58. Biosimilars Market in Nigeria; Market Size (US$ Billion), (2014-2022)

Table 59. Biosimilars Market in Rest of Middle East& Africa; Market Size (US$ Billion), (2014-2022)

Table 60. Biosimilars Market in Middle East & Africa; Market Size (US$ Billion), By Product Type (2014-2022)

Table 61. Biosimilars Market in Middle East & Africa; Market Size (US$ Billion), By Applications (2014-2022)

Table 62. Biosimilars Market in Latin America; Market Size (US$ Billion)

Table 63. Biosimilars Market in Brazil; Market Size (US$ Billion), (2014-2022)

Table 64. Biosimilars Market in Argentina; Market Size (US$ Billion), (2014-2022)

Table 65. Biosimilars Market in Columbia; Market Size (US$ Billion), (2014-2022)

Table 66. Biosimilars Market in Mexico; Market Size (US$ Billion), (2014-2022)

Table 67. Biosimilars Market in Rest of Latin America; Market Size (US$ Billion), (2014-2022)

Table 68. Biosimilars Market in Latin America; Market Size (US$ Billion), By Product Type (2014-2022)

Table 69. Biosimilars Market in Latin America; Market Size (US$ Billion), By Applications (2014-2022)

Table 70. Acronyms

 

LIST OF FIGURES

Figure 1. Research Methodology

Figure 2. Global Biosimilars Market Share(%), By Geography (2015 & 2022)

Figure 3. Global Biosimilars Market Share(%), By Product Type (2015 & 2022)

Figure 4. Global Biosimilars Market Share(%), By Applications (2015 & 2022)

Figure 5. Product Roadmap

Figure 6. Market Attractiveness forBiosimilars Set-up

Figure 7. Number of Biological Products going off-patent by 2022 in U.S.

Figure 8. Estimated sales of Biological Products going off-patent by 2022 in U.S (in Billion)

Figure 9. Biosimilars by Stage of Development (2016)

Figure 10. Number (in percentage) of Biosimilar Companies, By Geography (2016)

Figure 11. Global Biosimilars Market: Prescriber Acceptancevs. Patient Acceptance, By Geography (2015)

Figure 12. Market Attractiveness for different Biosimilars Product Segments

Figure 13. Global Biosimilars Market, By Product Segments: Market Size vs. Market Penetration(2015)

Figure 14. Global Biosimilars Market Share(%), By Product Type (2015 & 2022)

Figure 15. Global Biosimilars Market Size (US$ Billion), By Product Types (2014-2022)

Figure 16. Global Recombinant Glycosylated ProteinsBiosimilars Market Size (US$ Billion), By Regions (2015 & 2022)

Figure 17. Global Recombinant Non-Glycosylated ProteinsBiosimilars Market Size (US$ Billion), By Regions (2015 & 2022)

Figure 18. Global Recombinant PeptidesBiosimilars Market Size (US$ Billion), By Regions (2015 & 2022)

Figure 19. Global Biosimilars Market Size (US$ Billion), By Applications (2015)

Figure 20. Global Biosimilars Market Share (%), By Applications (2015 & 2022)

Figure 21. Global Biosimilars Market Size (US$ Billion), By Applications (2015 vs.2022)

Figure 22. Global Biosimilars Market for Oncology; Market Size (US$ Billion) (2015 & 2022)

Figure 23. Global Biosimilars Market for Blood Disorders; Market Size (US$ Billion) (2015 & 2022)

Figure 24. Global Biosimilars Market for Infectious Diseases; Market Size (US$ Billion) (2015 & 2022)

Figure 25. Global Biosimilars Market for Autoimmune Diseases; Market Size (US$ Billion) (2015 & 2022)

Figure 26. Global Biosimilars Market for Other Diseases; Market Size (US$ Billion) (2015 & 2022)

Figure 27. Global Biosimilars Market Share (%), By Major Regions(2015 & 2022)

Figure 28. Top 5 Countries, By Market Share (%) (2015)

Figure 29. Top 5 Countries, By Market Share (%) (2022)

Figure 30. Biosimilars Market in North America; Snapshot (2015)

Figure 31. Biosimilars Market in North America; Market Size (US$ Billion)(2014-2022)

Figure 32. Biosimilars Market in North America; Market Size (US$ Billion),By Product Type (2014-2022)

Figure 33. Biosimilars Market in North America; Market Size (US$ Billion),By Applications (2016 vs.2022)

Figure 34. Biosimilars Market in Europe; Snapshot (2015)

Figure 35. Biosimilars Market in Europe; Market Size (US$ Billion)(2014-2022)

Figure 36. Biosimilars Market in Europe; Market Size (US$ Billion),By Product Type (2014-2022)

Figure 37. Biosimilars Market in Europe; Market Size (US$ Billion),By Applications (2016 vs.2022)

Figure 38. Biosimilars Market in Asia-Pacific; Snapshot (2015)

Figure 39. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion)(2014-2022)

Figure 40. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion),By Product Type (2014-2022)

Figure 41. Biosimilars Market in Asia-Pacific; Market Size (US$ Billion),By Applications (2016 vs.2022)

Figure 42. Biosimilars Market in Middle East& Africa; Snapshot (2015)

Figure 43. Biosimilars Market in Middle East& Africa; Market Size (US$ Billion) (2014-2022)

Figure 44. Biosimilars Market in Middle East& Africa; Market Size (US$ Billion),By Product Segments(2014-2022)

Figure 45. Biosimilars Market in Middle East& Africa; Market Size (US$ Billion),By Applications (2016 vs.2022)

Figure 46. Biosimilars Market in Middle Latin America; Snapshot (2015)

Figure 47. Biosimilars Market in Latin America; Market Size (US$ Billion) (2014-2022)

Figure 48. Biosimilars Market in Latin America; Market Size (US$ Billion),By Product Type(2014-2022)

Figure 49. Biosimilars Market in Latin America; Market Size (US$ Billion),By Applications (2016 vs.2022)

Figure 50. Market Share (%) Analysis of Major Players, 2015

Inquiry Form

Thank you for contacting us.

Your form has been submitted successfully. Our representative will contact you shortly.

Warm regards,

James Johnson | Director and Sales Head
Telephone No: +1(857)2390696
Market.biz
E-mail: inquiry@market.biz | Web: www.market.biz

Request For Sample

Thank you for contacting us.

Your form has been submitted successfully. Our representative will contact you shortly.

Warm regards,

James Johnson | Director and Sales Head
Telephone No: +1(857)2390696
Market.biz
E-mail: inquiry@market.biz | Web: www.market.biz
Categories: Healthcare

GlobalMarketFacts

Stefen is working in advertising and journalism and has written for publications like Prudour Network, TFN, and GMF. He was an Editor of GMF and is now a consultant for them.